The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo

This publication has 21 references indexed in Scilit:

• Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
  The Journal of Infectious Diseases, 2001
• Resistance of influenza viruses to neuraminidase inhibitors — a review
  Antiviral Research, 2000
• In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir
  Virology, 1999
• Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza
  JAMA, 1999
• Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus
  The Journal of Infectious Diseases, 1998
• Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
  Antimicrobial Agents and Chemotherapy, 1998
• Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity
  Journal of the American Chemical Society, 1997
• Generation and Characterization of an Influenza Virus Neuraminidase Variant with Decreased Sensitivity to the Neuraminidase-Specific Inhibitor 4-Guanidino-Neu5Ac2en
  Virology, 1995
• Clinical and epidemiological importance of influenza a viruses resistant to amantadine and rimantadine
  Reviews in Medical Virology, 1992
• Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism
  Biochemistry, 1987